New mRNA-Based Therapy Effective in Treating Melanoma in Mouse Models
Investigators at the Icahn School of Medicine at Mount Sinai have designed an RNA-based strategy to activate dendritic cells, which play a key role in immune response, that eradicated tumors and prevented their recurrence in mouse models of melanoma.
Combination of IVIG and Corticosteroids Superior to Respective Monotherapies for Treatment of Relapsed ITP in Adults
The combination of intravenous immune globulin (IVIG) and corticosteroids is a more efficient and rapid treatment for relapsed immune thrombocytopenic purpura (ITP) in adults compared with the use of either therapy alone.
Early Albumin Administration May Reduce Mortality in Septic Shock and ARDS: Retrospective MIMIC III Database Study
A study has found that early albumin administration in septic shock patients with ARDS was independently associated with a reduction in 28-day mortality.
FDA Approves Antibody to Protect Infants Against RSV
The U.S. Food and Drug Administration (FDA) has approved nirsevimab to protect newborns from respiratory syncytial virus (RSV).
FDA Approves First Postpartum Depression Oral Treatment
The U.S. Food and Drug Administration has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.
Immunotherapy May Treat ALS, Says Study
A study led by scientists at Oregon Health & Science University has found that a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis (ALS).
HHS Forms the Office of Long COVID Research and Practice and Launch of Long COVID Clinical Trials
The U.S. Department of Health and Human Services has founded the Office of Long COVID Research and Practice to lead the Long COVID response and coordination across the federal government. In addition, the National Institutes of Health launched Long COVID clinical trials through the RECOVER Initiative.
$147 Million Awarded to Help End the HIV Epidemic in the U.S.
The U.S. Department of Health and Human services has awarded more than $147 million to 49 recipients to advance the Ending the HIV Epidemic in the U.S. initiative, which is part of the ongoing efforts to reduce the number of new infections in the United States by at least 90 percent by 2030.
HHS Makes $25 Million Available to Expand Primary Care Services in Schools
Through the Health Resources and Services Administration, the U.S. Department of Health and Human Services has announced the availability of approximately $25 million to expand primary healthcare, including mental health services, in schools.
Medicare Dementia Care Model Is Established by HHS
The Guiding an Improved Dementia Experience (GUIDE) Model, which aims to improve the quality of life for people living with dementia, reduce strain on unpaid caregivers, and help people remain in their homes and communities through a package of care coordination and management, caregiving education and support, and respite services has been established by the U.S. Department of Health and Human Services.